细胞内
微生物学
抗生素
细胞内寄生虫
类鼻疽伯克霍尔德菌
伯克氏菌属
纳米囊
生物
细菌
生物化学
材料科学
纳米技术
遗传学
纳米颗粒
作者
Eleanor Porges,Dominic C. Jenner,Adam W. Taylor,James S. P. Harrison,Antonio De Grazia,Alethia R. Hailes,Kimberley M. Wright,Adam O. Whelan,Isobel H. Norville,Joann L. Prior,Sumeet Mahajan,Caroline A. Rowland,Tracey A. Newman,Nicholas D. Evans
出处
期刊:ACS Nano
[American Chemical Society]
日期:2021-11-05
卷期号:15 (12): 19284-19297
被引量:13
标识
DOI:10.1021/acsnano.1c05309
摘要
Melioidosis caused by the facultative intracellular pathogen Burkholderia pseudomallei is difficult to treat due to poor intracellular bioavailability of antibiotics and antibiotic resistance. In the absence of novel compounds, polymersome (PM) encapsulation may increase the efficacy of existing antibiotics and reduce antibiotic resistance by promoting targeted, infection-specific intracellular uptake. In this study, we developed PMs composed of widely available poly(ethylene oxide)-polycaprolactone block copolymers and demonstrated their delivery to intracellular B. thailandensis infection using multispectral imaging flow cytometry (IFC) and coherent anti-Stokes Raman scattering microscopy. Antibiotics were tightly sequestered in PMs and did not inhibit the growth of free-living B. thailandensis. However, on uptake of antibiotic-loaded PMs by infected macrophages, IFC demonstrated PM colocalization with intracellular B. thailandensis and a significant inhibition of their growth. We conclude that PMs are a viable approach for the targeted antibiotic treatment of persistent intracellular Burkholderia infection.
科研通智能强力驱动
Strongly Powered by AbleSci AI